Walleye Trading
ARKG icon

Walleye Trading’s ARK Genomic Revolution ETF ARKG Stock Holding History

Walleye Trading’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.53M Buy
57,900
+20,700
+56% +$606K ﹤0.01% 1867
2025
Q4 		$1.08M Sell
37,200
-16,100
-30% -$483K ﹤0.01% 2325
2025
Q3 		$1.48M Sell
53,300
-25,100
-32% -$634K ﹤0.01% 2006
2025
Q2 		$1.91M Buy
78,400
+18,000
+30% +$394K ﹤0.01% 1751
2025
Q1 		$1.25M Buy
60,400
+2,400
+4% +$60.3K ﹤0.01% 1924
2024
Q4 		$1.37M Sell
58,000
-4,300
-7% -$106K ﹤0.01% 1935
2024
Q3 		$1.59M Sell
62,300
-3,500
-5% -$89.1K ﹤0.01% 1820
2024
Q2 		$1.54M Buy
65,800
+15,100
+30% +$381K ﹤0.01% 1769
2024
Q1 		$1.46M Sell
50,700
-36,800
-42% -$1.11M ﹤0.01% 1943
2023
Q4 		$2.87M Sell
87,500
-300
-0.3% -$8.16K 0.01% 1637
2023
Q3 		$2.45M Sell
87,800
-9,600
-10% -$314K 0.01% 1636
2023
Q2 		$3.32M Sell
97,400
-12,800
-12% -$402K 0.01% 1273
2023
Q1 		$3.31M Sell
110,200
-34,400
-24% -$1.07M 0.01% 1346
2022
Q4 		$4.08M Buy
144,600
+36,900
+34% +$1.17M 0.01% 1197
2022
Q3 		$3.54M Buy
107,700
+11,900
+12% +$437K 0.01% 1272
2022
Q2 		$3.02M Buy
95,800
+17,600
+23% +$615K 0.01% 1353
2022
Q1 		$3.59M Buy
+78,200
New +$3.73M 0.01% 1216
2021
Q4 		– Sell
-6,400
Closed -$478K – 5314
2021
Q3 		$478K Sell
6,400
-14,700
-70% -$1.23M ﹤0.01% 2962
2021
Q2 		$1.95M Buy
21,100
+17,200
+441% +$1.46M 0.01% 1520
2021
Q1 		$346K Buy
+3,900
New +$387K ﹤0.01% 3076

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Walleye Trading's ARKG Position: Q1 2026 in Review

Walleye Trading reduced its ARK Genomic Revolution ETF (ARKG) stake by 20% in Q1 2026, selling an estimated $523K and leaving 70,990 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #1750.

Walleye Trading first reported a position in ARKG in Q3 2021 and has held it in 8 quarters since. The position peaked at $4M in Q4 2023. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Walleye Trading held 70,990 shares of ARK Genomic Revolution ETF worth $1.88M as of Q1 2026.
  • Walleye Trading sold 17,849 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $523K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #1750 holding.
  • Walleye Trading first reported a position in ARK Genomic Revolution ETF in Q3 2021 and has held it in 8 quarters since.
  • Walleye Trading's ARK Genomic Revolution ETF position peaked at $4M in Q4 2023.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.